Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,452 total articles
D-Wave (QBTS) is a rare pure-play quantum vendor with real customers and billing today. That reality has driven a sky-high valuation: market cap roughly $6.28B, price-to-sales north of 250x, and negative EPS. The trade: short QBTS at $18.23 with a mid-term (45 trading days) target of $12.00 and a stop at $21.50. The thesis rests on mean reversion f…
Talen Energy (TLN) combines predictable wholesale power cash flow with a growing digital infrastructure pivot. Recent acquisitions, AWS tie-ups, and the structural tailwind of AI-driven data-center power demand make TLN a compelling long opportunity. This trade plan sets an entry at $347.50, stop at $320.00, and target at $480.00 over a 180 trading…
Pagaya is an AI-first credit infrastructure company trading at an attractive multiple after a strategic pivot to an asset-light model. At roughly $13.10 today and a market cap near $1.07B, the company shows strong free cash flow generation, improving profitability and sensible valuation metrics. This is a long-biased trade idea with defined entry, …
BYD should see demand and margin upside in 2H26 as refreshed models, iterative software and battery improvements re-accelerate deliveries and ASPs. This is a medium-risk, long-term trade to capture the expected rebound; plan for a disciplined entry at $35.00, stop at $28.00 and target of $48.00 over the next 180 trading days.
Newmont is the world’s largest gold miner with a simplified portfolio, industry-leading free cash flow, and a conservative balance sheet. At $119.30 the stock still prices in too much macro risk and not enough structural optionality. This trade backs a long position sized for conviction with an explicit entry, stop, and target and a clear horizon.
Sandisk (SNDK) remains a top trade in AI-related hardware. Strong momentum, ongoing NAND supply tightness, and index inclusion catalyze more upside. I outline a concrete swing trade with entry, stop and target, plus the risks that could derail the thesis.
Oracle has caught a bid after AI infrastructure headlines and a Bloom Energy power deal, but the market's skepticism persists: valuation metrics, negative free cash flow, and elevated debt ratios keep expectations muted. I see asymmetric upside into $235 over the next 180 trading days if execution on data-center spending and RPO converts to cash fl…
Warrior Met Coal (HCC) is a low-cost metallurgical coal producer with a strong liquidity position, limited leverage and a premium product that remains essential to steelmaking. After a pullback to $85.78, the stock offers a favorable risk/reward for a mid-term bounce toward prior highs, supported by tight supply dynamics and continued export demand…
SkyWest (SKYW) looks attractively valued heading into Q1. At roughly $98 per share, the stock trades at a P/E near 9.2 and an EV/EBITDA of about 6.3, while generating meaningful free cash flow. Operational exposure to major network partners is a double-edged sword, but near-term catalysts and an improving technical setup support a mid-term long tra…
Amazon's renewed focus on Zoox and its cloud/AI partnerships creates a visible asymmetric opportunity. With enterprise AI adoption accelerating and semiconductor demand still strong, AMZN looks poised for a re-rating if management can translate mobility and Anthropic-related AI investments into clearer revenue paths. This trade sets a disciplined l…
ASML reported better-than-expected Q1 results, raised full-year guidance and stepped up capital returns. The company's duopoly in extreme ultraviolet lithography and strong AI-driven capex by hyperscalers underpin defendable growth. Valuation is rich but not disconnected from the profit pool ASML controls. This trade idea offers a precise entry, st…
Niagen looks like a business with durable growth characteristics that the market has temporarily discounted. With a clear entry at $18.50, a stop at $15.00 and a $27.00 target, this trade balances upside potential with controlled downside for a mid-term swing lasting 45 trading days.
Idaho Strategic Resources (IDR) looks set to re-rate. Positive earnings beats, low leverage, strong free cash flow for its size and bullish technicals argue for a buy into $39.04 with a clear stop and tiered targets tied to catalysts such as gold price strength and project updates.
Vertiv (VRT) sits at the center of the AI infrastructure surge: a reported $15 billion backlog, accelerating order growth, and dominant liquid-cooling positions that hyperscalers need. The shares have run, but fundamentals and cash generation justify a mid-term long trade with defined risk. This note lays out the thesis, supporting numbers, catalys…
Talos Energy is trading cheaply relative to its cash generation and assets. Improved capital efficiency, a meaningful FCF run-rate and upcoming Gulf of Mexico production catalysts support a long trade into $18 over the next 180 trading days, with a defined stop to control downside.
SolarEdge's shares have more than doubled over the last 12 months. The company's scale in inverters, a meaningful free cash flow runway, and renewed demand signals tied to oil-market volatility create a high-probability swing trade. Entry at $43, stop at $38, target $52 over a mid-term (45 trading days) horizon balances upside potential and event r…
Cathay General Bancorp (CATY) offers a compelling risk-reward: attractive valuation (P/E ~11.4, P/B ~1.23), strong cash generation (free cash flow $363.7M) and a $125M buyback program. Combine those with a 2.6% yield and conservative leverage and the setup supports a mid-term trade to $60 with a $50 stop.
Hims & Hers ($21.39) trades like a litigation-and-GLP-1 story rather than a consumer-telehealth business with recurring revenue and positive free cash flow. With a $4.87B market cap and enterprise value of ~$5.56B, the stock is pricing in a worst-case outcome. I think the market has overshot. Buy a tactical swing to position trade with an entry at …
ONEOK (OKE) is a cash-flowing midstream operator trading at ~15.8x earnings with a 4.8-5.1% yield, funded expansion projects coming online through 2028, and a balance sheet that supports steady distributions. This trade targets a rebound to the 52-week high as projects de-risk and natural gas/NGL fundamentals firm.
Nokia has moved from deep recovery into a structurally relevant growth narrative driven by AI-related optical networking demand and strategic partnerships. At roughly $10.40, the stock is no longer a deep-value punt but a tactical long with defined risk/reward: enter above $10.00, target Bank of America's $12.40 thesis in the mid-term, and use a ti…
Saudi Aramco remains one of the most consequential energy stories globally. For traders willing to take a measured, event-driven long, Aramco offers a compelling risk-reward: strong cash generation, sovereign support, and continuing demand resilience. This trade targets a bounce while preserving capital with a tight stop and a clear time horizon ti…
TTD has reset expectations after a damaging public dispute with a major agency and an executive exodus. Fundamentals - including roughly $2.9B in revenue, $796M free cash flow and roughly $10B market cap - still support recovery, but short interest and client scrutiny create asymmetric outcomes. This trade targets a mid-term rebound to $28 with a p…
Broadcom's leadership in custom AI silicon and strong guidance make it a compelling long. The company's Q2 revenue guide of $22B and management's projection of >$100B AI chip revenue by 2027 underpin near-term upside, but rich multiples and an overbought technical backdrop require disciplined sizing and a protective stop.
Amazon's AI and cloud momentum — including over $15 billion in annualized AI revenue at AWS — is colliding with headlines about a $200 billion data-center program. That program looks scary on the headlines, but the company's fundamentals, capital structure, and cash generation profile argue against forced deleveraging. This is a swing trade: buy th…
Revolution Medicines (RVMD) surged after 04/13/2026 Phase 3 RASolute 302 results showed daraxonrasib doubled overall survival versus chemo in metastatic pancreatic cancer (13.2 vs. 6.7 months). With a market cap near $29.07B, strong balance-sheet metrics and a clear regulatory path, the stock has runway for further upside — but expect volatility. T…
